Combination immuno-oncology therapy with immune checkpoint blockers targeting PD-L1, PD-1 or CTLA4 and epigenetic drugs targeting MYC and immune evasion for precision medicine

联合免疫肿瘤疗法，包括靶向PD-L1、PD-1或CTLA4的免疫检查点阻断剂和靶向MYC及免疫逃逸的表观遗传药物，用于精准医疗。